E. J. Thompson

1.2k total citations
31 papers, 887 citations indexed

About

E. J. Thompson is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, E. J. Thompson has authored 31 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Neurology. Recurrent topics in E. J. Thompson's work include Multiple Sclerosis Research Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cell Adhesion Molecules Research (3 papers). E. J. Thompson is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cell Adhesion Molecules Research (3 papers). E. J. Thompson collaborates with scholars based in United Kingdom, Poland and United States. E. J. Thompson's co-authors include Gavin Giovannoni, Axel Petzold, Richard Luxton, R.H.C. Lazeron, Geoff Keir, Frederik Barkhof, Chris H. Polman, Bernard M.J. Uitdehaag, Merijn Eikelenboom and Konrad Rejdak and has published in prestigious journals such as The Journal of Immunology, Neurology and Journal of Neurochemistry.

In The Last Decade

E. J. Thompson

31 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. J. Thompson United Kingdom 16 420 284 199 158 137 31 887
Vera Lehmensiek Germany 15 251 0.6× 269 0.9× 212 1.1× 227 1.4× 92 0.7× 22 848
Peter A. Csurhes Australia 20 462 1.1× 264 0.9× 154 0.8× 440 2.8× 123 0.9× 39 1.2k
David Brassat France 18 450 1.1× 269 0.9× 296 1.5× 249 1.6× 159 1.2× 40 1.0k
Emilia L. Oleszak United States 19 466 1.1× 137 0.5× 309 1.6× 474 3.0× 84 0.6× 46 1.4k
M. Pette Germany 14 368 0.9× 280 1.0× 206 1.0× 755 4.8× 70 0.5× 28 1.3k
Samia Ragheb United States 13 220 0.5× 390 1.4× 80 0.4× 205 1.3× 57 0.4× 23 798
B. Kitze Germany 10 467 1.1× 110 0.4× 141 0.7× 607 3.8× 136 1.0× 19 990
James B. Burns United States 17 179 0.4× 176 0.6× 123 0.6× 466 2.9× 52 0.4× 40 871
Markus C. Kowarik Germany 15 483 1.1× 289 1.0× 168 0.8× 357 2.3× 91 0.7× 48 977
V. Navikas Sweden 16 417 1.0× 151 0.5× 184 0.9× 667 4.2× 176 1.3× 24 1.2k

Countries citing papers authored by E. J. Thompson

Since Specialization
Citations

This map shows the geographic impact of E. J. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. J. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. J. Thompson more than expected).

Fields of papers citing papers by E. J. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. J. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. J. Thompson. The network helps show where E. J. Thompson may publish in the future.

Co-authorship network of co-authors of E. J. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of E. J. Thompson. A scholar is included among the top collaborators of E. J. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. J. Thompson. E. J. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hawkes, Christopher H., Gavin Giovannoni, Geoff Keir, Marianne Cunnington, & E. J. Thompson. (2006). Seroprevalence of herpes simplex virus type 2 in multiple sclerosis. Acta Neurologica Scandinavica. 114(6). 363–367. 17 indexed citations
2.
Petzold, Axel, Konrad Rejdak, Antonio Belli, et al.. (2005). Axonal Pathology in Subarachnoid and Intracerebral Hemorrhage. Journal of Neurotrauma. 22(3). 407–414. 37 indexed citations
3.
Eikelenboom, Merijn, Axel Petzold, R.H.C. Lazeron, et al.. (2003). Multiple sclerosis. Neurology. 60(2). 219–223. 105 indexed citations
4.
Giovannoni, Gavin, Nicholas Silver, Catriona D. Good, D. H. Miller, & E. J. Thompson. (2000). Immunological Time-Course of Gadolinium-Enhancing MRI Lesions in Patients with Multiple Sclerosis. European Neurology. 44(4). 222–228. 11 indexed citations
5.
Jackman, R., et al.. (1999). Increased S‐lOOb in the cerebrospinal fluid of some cattle with bovine spongiform encephalopathy. Veterinary Record. 145(4). 107–109. 7 indexed citations
6.
Giovannoni, Gavin, Nicholas Silver, Catriona D. Good, et al.. (1998). Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis. Journal of Neuroimmunology. 90(1). 97–97. 1 indexed citations
7.
Thompson, E. J., et al.. (1998). Protein markers of brain damage. Multiple Sclerosis Journal. 4(1). 5–6. 2 indexed citations
8.
Deisenhammer, Florian, Robert F. Miller, Nicola S. Brink, Michael Harrison, & E. J. Thompson. (1997). Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.. Sexually Transmitted Infections. 73(3). 181–183. 15 indexed citations
9.
Thompson, E. J., María Trojano, & Paolo Livrea. (1996). Cerebrospinal Fluid Analysis in Multiple Sclerosis. 3 indexed citations
10.
Sharief, M. K., Maria Rosa Ciardi, E. J. Thompson, et al.. (1992). Tumour necrosis factor‐α mediates blood—brain barrier damage in HIV‐1 infection of the central nervous system. Mediators of Inflammation. 1(3). 191–196. 8 indexed citations
11.
Sharief, M. K., et al.. (1992). Determination of interleukin-2 in cerebrospinal fluid by a sensitive enzyme-linked immunosorbent assay. Journal of Immunological Methods. 147(1). 51–56. 8 indexed citations
12.
Luxton, Richard, et al.. (1992). IgG paraproteins in neurological diseases: lack of association with neurotropic viral/bacterial antigens. Acta Neurologica Scandinavica. 86(6). 596–598. 1 indexed citations
13.
Luxton, Richard & E. J. Thompson. (1990). Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis. Journal of Immunological Methods. 131(2). 277–282. 41 indexed citations
14.
Sharief, M. K. & E. J. Thompson. (1990). A sensitive ELISA system for the rapid detection of virus specific IgM antibodies in the cerebrospinal fluid. Journal of Immunological Methods. 130(1). 19–24. 7 indexed citations
15.
Thompson, E. J.. (1987). Advances in CSF protein research and diagnosis. 23 indexed citations
16.
Wimperis, J. Z., Malcolm K. Brenner, H. G. Prentice, E. J. Thompson, & A. V. Hoffbrand. (1987). B cell development and regulation after T cell-depleted marrow transplantation.. The Journal of Immunology. 138(8). 2445–2450. 31 indexed citations
17.
Horner, G.W., R. Hunter, & E. J. Thompson. (1980). Isolation and characterization of a new adenovirus serotype from a yearling heifer with systemic infection. New Zealand Veterinary Journal. 28(8). 165–167. 13 indexed citations
18.
Thompson, E. J., et al.. (1979). Observations of cat leprosy. New Zealand Veterinary Journal. 27(11). 233–235. 15 indexed citations
19.
Thompson, E. J.. (1977). Current trends in sphingolipidoses and allied disorders. Journal of the Neurological Sciences. 32(2). 303–303. 31 indexed citations
20.
Davis, G.B., et al.. (1975). Hereditary neuraxial oedema of calves. New Zealand Veterinary Journal. 23(8). 181–181. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026